Feature

Doctors have failed them, say those with transgender regret


 

Lack of evidence-based, informed consent

Michelle Alleva, who stopped identifying as transgender in 2020 but had ceased testosterone 4 years earlier because of side effects, cited what she called a lack of evidence base for the effectiveness and safety of medical transitions.

“You need to have a really, really good evidence base in place if you’re going straight to an invasive treatment that is going to cause permanent changes to your body,” she said.

Access to medical transition used to involve more “gatekeeping” through mental health evaluations and other interventions, she said, but there has been a shift from treating what was considered a psychiatric issue to essentially affirming an identity.

“This shift was activist driven, not evidence based,” she emphasized.

Most studies showing satisfaction with transition only involve a few years of follow-up, she said. She added that the longest follow-up study of transition, published in 2011 and spanning 30 years, showed that the suicide rate 10-15 years post surgery was 20 times higher than the general population.

Studies of regret were primarily conducted before the rapid increase in the number of trans-identifying individuals, she said, which makes it hard to draw conclusions about pediatric transition. Getting estimates on this population is difficult because so many who detransition do not tell their clinicians, and many studies have short follow-up times or a high loss to follow-up.

Ms. Alleva also took issue with the notion that physicians were offering true informed consent, noting that it’s not possible to know if someone is psychologically sound if they haven’t had a thorough mental health evaluation and that there are so many unknowns with medical transition, including that many of the therapies are not approved for the uses being employed.

With regret on the rise, “we need professionals that are prepared for detransitioners,” said Ms. Alleva. “Some of us have lost trust in health care professionals as a result of our experience.”

“It’s a huge feeling of institutional betrayal,” said Grace.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA OKs iPLEDGE change for gender-neutral language
MDedge Internal Medicine
HHS okays first U.S. pilot to mandate coverage of gender-affirming care
MDedge Internal Medicine
FDA issues stronger safety requirements for breast implants
MDedge Internal Medicine
Detransitioners received poor evaluation when transitioning
MDedge Internal Medicine
The significance of Transgender Awareness Week
MDedge Internal Medicine
‘Top’ surgery for trans youth: Advance or dangerous medicine?
MDedge Internal Medicine
LGBTQ health care: There is reason to be hopeful
MDedge Internal Medicine
Risk for severe COVID-19 and death plummets with Pfizer booster
MDedge Internal Medicine
WPATH draft on gender dysphoria ‘skewed and misses urgent issues’
MDedge Internal Medicine
Proposed insurance policy ignites debate over transgender health care
MDedge Internal Medicine